Global Digital Therapeutics and Wellness Market Overview

Global Digital Therapeutics and Wellness Market was valued at USD 6.01 Billion in 2023 and is expected to reach USD 32.07 Billion by 2032, at a CAGR of 20.45%.

Digital therapeutics (DTx) is a digital health category referred by the Digital Therapeutics Alliance as products that provide evidence-based therapeutic involvement to patients that are turned by high-quality software programs to prevent, manage, or treat a medical disorder or disease. Digital therapeutics are distinct from digital medicines or “smart pills,” which combine a prescription medication with an ingestible sensor that is designed to communicate with a software application to track compliance. Development in and the increasingly dominant role of mobile technology and artificial intelligence (AI) in our everyday lives have expanded the role of digital therapeutics and wellness in healthcare. Even though historically, interest in emerging digital therapeutics was mainly confined to academia and technology companies, the potential to use digital therapeutics in conjunction with medicines to enhance health outcomes has sparked the interest of big pharma, who have started to venture into the digital therapeutics space through investments and strategic partnerships with tech companies. The rise in the tech-savvy population and the growing inclination towards software applications for yoga, exercise, and diet solutions is expected to propel the growth of the digital therapeutics and wellness market over the forecast period.

Market Dynamics And Key Factors For Digital Therapeutics and Wellness Market

Drivers:

The pandemic has triggered an increase in virtual care practice in the remote and home healthcare segments across the world. As Digital Therapeutics interventions are commonly delivered through smartphones, tablets, or IoT devices, new cloud-based platforms provide online diagnosis and consultation. Many blue ocean companies are start-ups are investing in AI-based digital platforms to create a streamlined solution and consulting systems can be provided to a larger crowd to treat chronic illness and mental health therapies. Such health condition needs a serious and quick response from the health care provider which is certainly the main key driving factor for Digital Therapeutic and wellness market growth. With the service base solution, many advanced tech companies investing in the development of digital health devices which can provide vital assistance as well as diagnosis promptly.

New-gen smart heart monitoring devices, diabetic control devices, blood glucose sensors, and blood pressure monitors have evolved by integration of machine learning, big data, and Artificial Intelligence to provide high accuracy data and diagnosis which is certainly driving the digital therapeutics and wellness market in the projected timeframe. The rise in adoption of smartphones and tablets, coupled with healthcare apps, growth in need to control healthcare cost, significant benefits to the entire healthcare continuum, and increase in incidences of chronic diseases increased the adoption of solutions offered by digital therapeutics. Digital therapeutics has made the management of diabetes, hypertension, blood pressure, and smoking convenient due to software-based applications and live tutorials on a smartphone thus, strengthening the expansion of the digital therapeutics and wellness market throughout the projected timeframe.

Restraints:

Digital Therapeutics and wellness solutions are based on connectivity, cloud-based infrastructure, and valuable data transfer. Due to the sensitive data exposed on web-based platforms, there is a high risk of data security which can be crucial in case of data heist or cyber-attack on such servers. Cybersecurity and data rights are the main requirements for the mass adoption of digital therapeutics solutions. Moreover, Digital Therapeutics devices such as connected sensors in medicines and heart monitoring devices, as a digital treatment that transfer information over the internet have a certain risk of unauthorized access and manipulation of these devices and underlying data could compromise both trust in the product and patient care thus, hampering the development of the digital therapeutics and wellness market in the forecasted period.

Opportunities:

The Technological shift in digital tools and devices integrated into daily lifestyle provides a certain opportunity in creating digital health integrated platforms and solutions as increasing dominance of mobile technology and artificial intelligence and IoT devises in everyday activity. These market trends are a suitable opportunity for Digital Therapeutics and wellness companies to integrate new prospects such as electronic health records, virtual visits, mobile health, wearable technology, artificial intelligence, and machine learning in digital therapeutics. Progress of therapeutic applications in various range of neuroscience indications like attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), Schizophrenia, Depression, and bipolar disorder provides scope for commercial research and development. Moreover, the growing usage of smartphones and the ready adoption of digital treatment services can create a profitable opportunity for the market players.

Market Segmentation

Segmentation Analysis of Digital Therapeutics and Wellness Market:

Depending on device type, the blood pressure monitor segment is forecasted to have the highest share of the digital therapeutics and wellness market. Blood pressure should be monitored because long-term high blood pressure can damage arteries and the heart. It is feasible to assess if drugs are needed or effective by measuring blood pressure. Home usage digital blood pressure monitors are not only designed to check blood pressure but also measures pulse rate, and can detect an irregular heartbeat. The growing prevalence of diabetes and other disorders that directly affects blood pressure has stimulated the adoption of digital blood pressure monitors thus, consolidating the development of the segment.

Depending on the technology, cellular technology is anticipated to lead the growth of the digital therapeutics and wellness market in the analyzed period. Telemedicine/Telehealth and mHealth are the two main categories developed due to the advancement in cellular technology. With the growing usage of mobile devices (e.g., smartphones, tablets) in everyday lives, people have the ability to communicate and share information faster than ever before. As a result, innovative apps focused on enhancing health and healthcare delivery for individuals with limited access have been developed. Hospice care, which is commonly provided at home, may particularly benefit from the usage of this technology platform. Multiple potential benefits are offered by mobile health (mHealth) applications and these can be incorporated into existing home hospice care. Mobile health is freeing healthcare devices of wires and cords and enabling physicians and patients alike to check on healthcare processes on the go thus, helping the growth of this segment.

Depending on end-use, the obesity weight loss segment is expected to dominate the digital therapeutics and wellness market during the projected timeframe. The usage of a digital therapeutics platform in people with obesity and metabolic syndrome can lead to a reduction in both weight and body mass index (BMI), this reduces the likelihood of comorbidities, according to research presented at the American Association of Clinical Endocrinologists' 30th Annual Scientific and Clinical Congress. Clinicians can use digital therapeutic platforms to provide lifestyle-modification therapies remotely. Even in resource-constrained settings, these treatments have the potential to affect weight reduction in persons with obesity and metabolic syndrome by providing evidence-based care. Digital therapeutics can help patients remotely manage their weight and calorie intake thus, driving the growth of this segment.

Regional Analysis of Digital Therapeutics and Wellness Market:

The North American region is expected to have the lion's share of the digital therapeutics and wellness market throughout the forecast period. According to Bigfoot Biomedical Inc, approximately 2 million individuals in America utilize continuous glucose monitoring devices (CGM) to monitor their glucose levels. These devices check the blood glucose at specific intervals and then depending on the level of insulin automatically pump insulin or alert the wearer to take an insulin shot. The growing popularity of CGM devices along with other digital equipment among individuals is strengthening the expansion of the digital therapeutics and wellness market in this region.

The European region is anticipated to have the second-highest share of the digital therapeutics and wellness market. According to Statista, the number of people utilizing digital therapeutics in Europe was 6.4 million in the year 2020. This number is expected to reach 160.3 million by 2027. The growing prevalence of hypertension and other disorders that leads to hypertension has stimulated the usage of digital blood pressure monitors. According to Europa, 22% of the people aged 15 years and above reported high blood pressure in 2019. The convenience offered by digital blood pressure monitors has stimulated the rapid adoption of these devices thus, supporting the growth of the digital therapeutics and wellness market in this region over the projected period.

The digital therapeutics and wellness market in the Asia-Pacific region is expected to register the highest CAGR growth in the forecast period. The growing adoption of smart technologies and the inclination towards smart devices to monitor glucose, and blood pressure has boosted the growth of the market in this region. Digital wellness applications offered by market players are widely utilized by individuals in this region to quit smoking and alcohol consumption. People suffering from depression are also using this app to overcome it thus, the demand for digital therapeutics and wellness applications is expected to exponentially rise in this region throughout the forecast period.

Players Covered in Digital Therapeutics and Wellness Market are:

• Proteus Digital Health
• Omada Health
• Welldoc
• A&D
• Omron
• Qardio
• Virgin Pulse
• Livongo Health
• Noom
• Ginger
• Propeller Health
• 2morrow
• Canary Health
• Mango Health
• My mHealth
• Glytec
• Proteus
• Vida Health
• Blue Mesa Health
• Click Therapeutics
• CureApp
• Digital Therapeutics Inc
• Akili Interactive Labs
• AppliedVR
• Brain Power
• 7Cups
• Calm
• Fitbit
• Onlife Health
• Provant Health
• WellDoc
• Twine Health
• Medtronic
• Big Health and others major players.

COVID-19 Impact on Digital Therapeutics and Wellness Market

COVID-19 pandemic can be considered as the main factor that has stimulated the rapid expansion of the digital therapeutics and wellness market. Digitalization of healthcare was already perceived to be inevitable, representing the future of healthcare delivery across the world. Many digital health solutions have been launched to help in general wellness and health maintenance, as well as illness screening and diagnosis, treatment, and prognosis estimation. The term 'Digital Therapeutics (DTx)' refers to evidence-based digital treatments that are designed to offer therapy for certain disease domains and function primarily by inducing behavioral changes out of all of these solutions. In North America, there has been a climb in care about progressed prosperity, abhorrence of real visits to offices to reduce the credibility of infection, and development in mental wellbeing issues raised interest for modernized therapeutics during the Covid-19 pandemic. Digital therapeutics new organizations and driving players have been tending to conditions, for instance, Type 2 diabetes, impulse, compound lop-sidedness, and musculoskeletal injuries through video meetings, conveying instructive accounts and destinations on their locales, and scattering clinical benefits programs through applications. People have started mentioning solutions and clinical contraptions over web channels after receiving drugs and therapies remotely. To summarize, the COVID-19 pandemic has boosted the adoption rate of digital therapeutics and wellness solutions.

Recent Industry Developments In Digital Therapeutics and Wellness Market

• In August 2024, Pfizer Inc. launched PfizerForAll, a user-friendly digital platform to enhance healthcare access and wellness management for Americans. This comprehensive tool supports those affected by common illnesses such as migraine, COVID-19, and flu, while also assisting individuals seeking adult vaccinations. By consolidating essential resources and services into one accessible destination, PfizerForAll streamlines the process of obtaining care, filling prescriptions, and discovering savings on Pfizer medications, ultimately helping families take important health actions more efficiently.
• In November 2024, NASHVILLE, Tenn. and AACHEN, Germany, – BehaVR and Fern Health have announced a merger to create RealizedCare, a digital care management solution for chronic pain. This innovative platform combines digital therapeutics with traditional services, addressing the rising demand for scalable, evidence-based mental and behavioral health solutions. With support from Grünenthal as a strategic investor, RealizedCare aims to transform chronic pain management for the 52 million adults affected in the U.S., delivering personalized, outcome-focused care.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Technology
 3.3 By End User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Digital Therapeutics And Wellness Market by Type
 5.1 Digital Therapeutics And Wellness Market Overview Snapshot and Growth Engine
 5.2 Digital Therapeutics And Wellness Market Overview
 5.3 Scales
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Scales: Grographic Segmentation
 5.4 Blood Pressure Monitors
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Blood Pressure Monitors: Grographic Segmentation
 5.5 Blood Glucose Monitoring System
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Blood Glucose Monitoring System: Grographic Segmentation
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Grographic Segmentation

Chapter 6: Digital Therapeutics And Wellness Market by Technology
 6.1 Digital Therapeutics And Wellness Market Overview Snapshot and Growth Engine
 6.2 Digital Therapeutics And Wellness Market Overview
 6.3 Cellular Technology
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Cellular Technology: Grographic Segmentation
 6.4 VR
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 VR: Grographic Segmentation
 6.5 Others
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Others: Grographic Segmentation

Chapter 7: Digital Therapeutics And Wellness Market by End User
 7.1 Digital Therapeutics And Wellness Market Overview Snapshot and Growth Engine
 7.2 Digital Therapeutics And Wellness Market Overview
 7.3 Cardiovascular Disease & Hypertension
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Cardiovascular Disease & Hypertension: Grographic Segmentation
 7.4 Diabetes & Prediabetes
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Diabetes & Prediabetes: Grographic Segmentation
 7.5 Obesity & Weight Loss
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Obesity & Weight Loss: Grographic Segmentation
 7.6 Smoking Cessation
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Smoking Cessation: Grographic Segmentation
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Digital Therapeutics And Wellness Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Digital Therapeutics And Wellness Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Digital Therapeutics And Wellness Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 PROTEUS DIGITAL HEALTH
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 OMADA HEALTH
 8.4 WELLDOC
 8.5 A&D
 8.6 OMRON
 8.7 QARDIO
 8.8 VIRGIN PULSE
 8.9 LIVONGO HEALTH
 8.10 NOOM
 8.11 GINGER
 8.12 PROPELLER HEALTH
 8.13 2MORROW
 8.14 CANARY HEALTH
 8.15 MANGO HEALTH
 8.16 MY MHEALTH
 8.17 GLYTEC
 8.18 PROTEUS
 8.19 VIDA HEALTH
 8.20 BLUE MESA HEALTH
 8.21 CLICK THERAPEUTICS
 8.22 CUREAPP
 8.23 DIGITAL THERAPEUTICS INC
 8.24 AKILI INTERACTIVE LABS
 8.25 APPLIEDVR
 8.26 BRAIN POWER
 8.27 7CUPS
 8.28 CALM
 8.29 FITBIT
 8.30 ONLIFE HEALTH
 8.31 PROVANT HEALTH
 8.32 WELLDOC
 8.33 TWINE HEALTH
 8.34 MEDTRONIC
 8.35 BIG HEALTH
 8.36 OTHERS MAJOR PLAYERS

Chapter 9: Global Digital Therapeutics And Wellness Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Scales
  9.2.2 Blood Pressure Monitors
  9.2.3 Blood Glucose Monitoring System
  9.2.4 Others
 9.3 Historic and Forecasted Market Size By Technology
  9.3.1 Cellular Technology
  9.3.2 VR
  9.3.3 Others
 9.4 Historic and Forecasted Market Size By End User
  9.4.1 Cardiovascular Disease & Hypertension
  9.4.2 Diabetes & Prediabetes
  9.4.3 Obesity & Weight Loss
  9.4.4 Smoking Cessation
  9.4.5 Others

Chapter 10: North America Digital Therapeutics And Wellness Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Scales
  10.4.2 Blood Pressure Monitors
  10.4.3 Blood Glucose Monitoring System
  10.4.4 Others
 10.5 Historic and Forecasted Market Size By Technology
  10.5.1 Cellular Technology
  10.5.2 VR
  10.5.3 Others
 10.6 Historic and Forecasted Market Size By End User
  10.6.1 Cardiovascular Disease & Hypertension
  10.6.2 Diabetes & Prediabetes
  10.6.3 Obesity & Weight Loss
  10.6.4 Smoking Cessation
  10.6.5 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Digital Therapeutics And Wellness Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Scales
  11.4.2 Blood Pressure Monitors
  11.4.3 Blood Glucose Monitoring System
  11.4.4 Others
 11.5 Historic and Forecasted Market Size By Technology
  11.5.1 Cellular Technology
  11.5.2 VR
  11.5.3 Others
 11.6 Historic and Forecasted Market Size By End User
  11.6.1 Cardiovascular Disease & Hypertension
  11.6.2 Diabetes & Prediabetes
  11.6.3 Obesity & Weight Loss
  11.6.4 Smoking Cessation
  11.6.5 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Digital Therapeutics And Wellness Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Scales
  12.4.2 Blood Pressure Monitors
  12.4.3 Blood Glucose Monitoring System
  12.4.4 Others
 12.5 Historic and Forecasted Market Size By Technology
  12.5.1 Cellular Technology
  12.5.2 VR
  12.5.3 Others
 12.6 Historic and Forecasted Market Size By End User
  12.6.1 Cardiovascular Disease & Hypertension
  12.6.2 Diabetes & Prediabetes
  12.6.3 Obesity & Weight Loss
  12.6.4 Smoking Cessation
  12.6.5 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Digital Therapeutics And Wellness Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Scales
  13.4.2 Blood Pressure Monitors
  13.4.3 Blood Glucose Monitoring System
  13.4.4 Others
 13.5 Historic and Forecasted Market Size By Technology
  13.5.1 Cellular Technology
  13.5.2 VR
  13.5.3 Others
 13.6 Historic and Forecasted Market Size By End User
  13.6.1 Cardiovascular Disease & Hypertension
  13.6.2 Diabetes & Prediabetes
  13.6.3 Obesity & Weight Loss
  13.6.4 Smoking Cessation
  13.6.5 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Digital Therapeutics And Wellness Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Scales
  14.4.2 Blood Pressure Monitors
  14.4.3 Blood Glucose Monitoring System
  14.4.4 Others
 14.5 Historic and Forecasted Market Size By Technology
  14.5.1 Cellular Technology
  14.5.2 VR
  14.5.3 Others
 14.6 Historic and Forecasted Market Size By End User
  14.6.1 Cardiovascular Disease & Hypertension
  14.6.2 Diabetes & Prediabetes
  14.6.3 Obesity & Weight Loss
  14.6.4 Smoking Cessation
  14.6.5 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. DIGITAL THERAPEUTICS AND WELLNESS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. DIGITAL THERAPEUTICS AND WELLNESS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. DIGITAL THERAPEUTICS AND WELLNESS MARKET COMPETITIVE RIVALRY
TABLE 005. DIGITAL THERAPEUTICS AND WELLNESS MARKET THREAT OF NEW ENTRANTS
TABLE 006. DIGITAL THERAPEUTICS AND WELLNESS MARKET THREAT OF SUBSTITUTES
TABLE 007. DIGITAL THERAPEUTICS AND WELLNESS MARKET BY TYPE
TABLE 008. SCALES MARKET OVERVIEW (2016-2028)
TABLE 009. BLOOD PRESSURE MONITORS MARKET OVERVIEW (2016-2028)
TABLE 010. BLOOD GLUCOSE MONITORING SYSTEM MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. DIGITAL THERAPEUTICS AND WELLNESS MARKET BY TECHNOLOGY
TABLE 013. CELLULAR TECHNOLOGY MARKET OVERVIEW (2016-2028)
TABLE 014. VR MARKET OVERVIEW (2016-2028)
TABLE 015. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 016. DIGITAL THERAPEUTICS AND WELLNESS MARKET BY END USER
TABLE 017. CARDIOVASCULAR DISEASE & HYPERTENSION MARKET OVERVIEW (2016-2028)
TABLE 018. DIABETES & PREDIABETES MARKET OVERVIEW (2016-2028)
TABLE 019. OBESITY & WEIGHT LOSS MARKET OVERVIEW (2016-2028)
TABLE 020. SMOKING CESSATION MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TYPE (2016-2028)
TABLE 023. NORTH AMERICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 024. NORTH AMERICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY END USER (2016-2028)
TABLE 025. N DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TYPE (2016-2028)
TABLE 027. EUROPE DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 028. EUROPE DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY END USER (2016-2028)
TABLE 029. DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TYPE (2016-2028)
TABLE 031. ASIA PACIFIC DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 032. ASIA PACIFIC DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY END USER (2016-2028)
TABLE 033. DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TYPE (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY END USER (2016-2028)
TABLE 037. DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TYPE (2016-2028)
TABLE 039. SOUTH AMERICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 040. SOUTH AMERICA DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY END USER (2016-2028)
TABLE 041. DIGITAL THERAPEUTICS AND WELLNESS MARKET, BY COUNTRY (2016-2028)
TABLE 042. PROTEUS DIGITAL HEALTH: SNAPSHOT
TABLE 043. PROTEUS DIGITAL HEALTH: BUSINESS PERFORMANCE
TABLE 044. PROTEUS DIGITAL HEALTH: PRODUCT PORTFOLIO
TABLE 045. PROTEUS DIGITAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. OMADA HEALTH: SNAPSHOT
TABLE 046. OMADA HEALTH: BUSINESS PERFORMANCE
TABLE 047. OMADA HEALTH: PRODUCT PORTFOLIO
TABLE 048. OMADA HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. WELLDOC: SNAPSHOT
TABLE 049. WELLDOC: BUSINESS PERFORMANCE
TABLE 050. WELLDOC: PRODUCT PORTFOLIO
TABLE 051. WELLDOC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. A&D: SNAPSHOT
TABLE 052. A&D: BUSINESS PERFORMANCE
TABLE 053. A&D: PRODUCT PORTFOLIO
TABLE 054. A&D: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. OMRON: SNAPSHOT
TABLE 055. OMRON: BUSINESS PERFORMANCE
TABLE 056. OMRON: PRODUCT PORTFOLIO
TABLE 057. OMRON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. QARDIO: SNAPSHOT
TABLE 058. QARDIO: BUSINESS PERFORMANCE
TABLE 059. QARDIO: PRODUCT PORTFOLIO
TABLE 060. QARDIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. VIRGIN PULSE: SNAPSHOT
TABLE 061. VIRGIN PULSE: BUSINESS PERFORMANCE
TABLE 062. VIRGIN PULSE: PRODUCT PORTFOLIO
TABLE 063. VIRGIN PULSE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. LIVONGO HEALTH: SNAPSHOT
TABLE 064. LIVONGO HEALTH: BUSINESS PERFORMANCE
TABLE 065. LIVONGO HEALTH: PRODUCT PORTFOLIO
TABLE 066. LIVONGO HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. NOOM: SNAPSHOT
TABLE 067. NOOM: BUSINESS PERFORMANCE
TABLE 068. NOOM: PRODUCT PORTFOLIO
TABLE 069. NOOM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. GINGER: SNAPSHOT
TABLE 070. GINGER: BUSINESS PERFORMANCE
TABLE 071. GINGER: PRODUCT PORTFOLIO
TABLE 072. GINGER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. PROPELLER HEALTH: SNAPSHOT
TABLE 073. PROPELLER HEALTH: BUSINESS PERFORMANCE
TABLE 074. PROPELLER HEALTH: PRODUCT PORTFOLIO
TABLE 075. PROPELLER HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. 2MORROW: SNAPSHOT
TABLE 076. 2MORROW: BUSINESS PERFORMANCE
TABLE 077. 2MORROW: PRODUCT PORTFOLIO
TABLE 078. 2MORROW: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. CANARY HEALTH: SNAPSHOT
TABLE 079. CANARY HEALTH: BUSINESS PERFORMANCE
TABLE 080. CANARY HEALTH: PRODUCT PORTFOLIO
TABLE 081. CANARY HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. MANGO HEALTH: SNAPSHOT
TABLE 082. MANGO HEALTH: BUSINESS PERFORMANCE
TABLE 083. MANGO HEALTH: PRODUCT PORTFOLIO
TABLE 084. MANGO HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. MY MHEALTH: SNAPSHOT
TABLE 085. MY MHEALTH: BUSINESS PERFORMANCE
TABLE 086. MY MHEALTH: PRODUCT PORTFOLIO
TABLE 087. MY MHEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. GLYTEC: SNAPSHOT
TABLE 088. GLYTEC: BUSINESS PERFORMANCE
TABLE 089. GLYTEC: PRODUCT PORTFOLIO
TABLE 090. GLYTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. PROTEUS: SNAPSHOT
TABLE 091. PROTEUS: BUSINESS PERFORMANCE
TABLE 092. PROTEUS: PRODUCT PORTFOLIO
TABLE 093. PROTEUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. VIDA HEALTH: SNAPSHOT
TABLE 094. VIDA HEALTH: BUSINESS PERFORMANCE
TABLE 095. VIDA HEALTH: PRODUCT PORTFOLIO
TABLE 096. VIDA HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 096. BLUE MESA HEALTH: SNAPSHOT
TABLE 097. BLUE MESA HEALTH: BUSINESS PERFORMANCE
TABLE 098. BLUE MESA HEALTH: PRODUCT PORTFOLIO
TABLE 099. BLUE MESA HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 099. CLICK THERAPEUTICS: SNAPSHOT
TABLE 100. CLICK THERAPEUTICS: BUSINESS PERFORMANCE
TABLE 101. CLICK THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 102. CLICK THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. CUREAPP: SNAPSHOT
TABLE 103. CUREAPP: BUSINESS PERFORMANCE
TABLE 104. CUREAPP: PRODUCT PORTFOLIO
TABLE 105. CUREAPP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. DIGITAL THERAPEUTICS INC: SNAPSHOT
TABLE 106. DIGITAL THERAPEUTICS INC: BUSINESS PERFORMANCE
TABLE 107. DIGITAL THERAPEUTICS INC: PRODUCT PORTFOLIO
TABLE 108. DIGITAL THERAPEUTICS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. AKILI INTERACTIVE LABS: SNAPSHOT
TABLE 109. AKILI INTERACTIVE LABS: BUSINESS PERFORMANCE
TABLE 110. AKILI INTERACTIVE LABS: PRODUCT PORTFOLIO
TABLE 111. AKILI INTERACTIVE LABS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111. APPLIEDVR: SNAPSHOT
TABLE 112. APPLIEDVR: BUSINESS PERFORMANCE
TABLE 113. APPLIEDVR: PRODUCT PORTFOLIO
TABLE 114. APPLIEDVR: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114. BRAIN POWER: SNAPSHOT
TABLE 115. BRAIN POWER: BUSINESS PERFORMANCE
TABLE 116. BRAIN POWER: PRODUCT PORTFOLIO
TABLE 117. BRAIN POWER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. 7CUPS: SNAPSHOT
TABLE 118. 7CUPS: BUSINESS PERFORMANCE
TABLE 119. 7CUPS: PRODUCT PORTFOLIO
TABLE 120. 7CUPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. CALM: SNAPSHOT
TABLE 121. CALM: BUSINESS PERFORMANCE
TABLE 122. CALM: PRODUCT PORTFOLIO
TABLE 123. CALM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 123. FITBIT: SNAPSHOT
TABLE 124. FITBIT: BUSINESS PERFORMANCE
TABLE 125. FITBIT: PRODUCT PORTFOLIO
TABLE 126. FITBIT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126. ONLIFE HEALTH: SNAPSHOT
TABLE 127. ONLIFE HEALTH: BUSINESS PERFORMANCE
TABLE 128. ONLIFE HEALTH: PRODUCT PORTFOLIO
TABLE 129. ONLIFE HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129. PROVANT HEALTH: SNAPSHOT
TABLE 130. PROVANT HEALTH: BUSINESS PERFORMANCE
TABLE 131. PROVANT HEALTH: PRODUCT PORTFOLIO
TABLE 132. PROVANT HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132. WELLDOC: SNAPSHOT
TABLE 133. WELLDOC: BUSINESS PERFORMANCE
TABLE 134. WELLDOC: PRODUCT PORTFOLIO
TABLE 135. WELLDOC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135. TWINE HEALTH: SNAPSHOT
TABLE 136. TWINE HEALTH: BUSINESS PERFORMANCE
TABLE 137. TWINE HEALTH: PRODUCT PORTFOLIO
TABLE 138. TWINE HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 138. MEDTRONIC: SNAPSHOT
TABLE 139. MEDTRONIC: BUSINESS PERFORMANCE
TABLE 140. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 141. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 141. BIG HEALTH: SNAPSHOT
TABLE 142. BIG HEALTH: BUSINESS PERFORMANCE
TABLE 143. BIG HEALTH: PRODUCT PORTFOLIO
TABLE 144. BIG HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 144. OTHERS MAJOR PLAYERS: SNAPSHOT
TABLE 145. OTHERS MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 146. OTHERS MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 147. OTHERS MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY TYPE
FIGURE 012. SCALES MARKET OVERVIEW (2016-2028)
FIGURE 013. BLOOD PRESSURE MONITORS MARKET OVERVIEW (2016-2028)
FIGURE 014. BLOOD GLUCOSE MONITORING SYSTEM MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY TECHNOLOGY
FIGURE 017. CELLULAR TECHNOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 018. VR MARKET OVERVIEW (2016-2028)
FIGURE 019. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 020. DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY END USER
FIGURE 021. CARDIOVASCULAR DISEASE & HYPERTENSION MARKET OVERVIEW (2016-2028)
FIGURE 022. DIABETES & PREDIABETES MARKET OVERVIEW (2016-2028)
FIGURE 023. OBESITY & WEIGHT LOSS MARKET OVERVIEW (2016-2028)
FIGURE 024. SMOKING CESSATION MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA DIGITAL THERAPEUTICS AND WELLNESS MARKET OVERVIEW BY COUNTRY (2016-2028)